Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
RESEARCH TOOLSreports
Supernus Pharmaceuticals (SUPN) Ownership Overview
4.33% Insiders
32.13% Mutual Funds
29.24% Other Institutional Investors
32.46% ETFs
1.83% Public Companies and Individual Investors
The ownership structure of Supernus Pharmaceuticals (SUPN) stock is a mix of institutional, retail, and individual investors. Approximately 93.84% of the company’s stock is owned by Institutional Investors, 4.33% is owned by Insiders, and 1.83% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 05, 2025 | Padmanabh Bhatt Sr. Vp Of Ip, Cso | xxxxxxxxxxxxx | $376237 |
| Jan 29, 2025 | Padmanabh Bhatt Sr. Vp Of Ip, Cso | xxxxxxxxxxxxx | $129676 |
| Dec 04, 2024 | Padmanabh Bhatt Sr. Vp Of Ip, Cso | xxxxxxxxxxxxx | $788437 |
| Nov 12, 2024 | Frederick Hudson Director | xxxxxxxxxxxxx | $316434 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $249793 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $467838 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1417905 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1699520 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,461,192 | Institution | 11.70% | 252,697,219 | |
| 5,497,076 | Institution | 9.95% | 214,990,642 | |
| 4,690,543 | Institution | 8.49% | 183,447,137 | |
| 1,995,690 | Institution | 3.61% | 78,051,436 | |
| 1,976,029 | Insider | 3.58% | 77,282,494 | |
| 1,699,603 | Institution | 3.08% | 66,471,473 | |
| 1,460,684 | Institution | 2.65% | 57,127,351 | |
| 1,050,222 | Institution | 1.90% | 41,074,182 | |
| 1,026,502 | Institution | 1.86% | 40,146,493 | |
| 1,015,660 | Institution | 1.84% | 39,722,463 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,690,543 | Institution | 8.49% | 183,447,137 | |
| 1,995,690 | Institution | 3.61% | 78,051,436 | |
| 1,699,603 | Institution | 3.08% | 66,471,473 | |
| 1,050,222 | Institution | 1.90% | 41,074,182 | |
| 667,407 | Institution | 1.21% | 26,102,288 | |
| 568,750 | Institution | 1.03% | 22,243,813 | |
| 548,772 | Institution | 0.99% | 21,462,473 | |
| 449,646 | Institution | 0.81% | 17,585,655 | |
| 391,717 | Institution | 0.71% | 15,320,052 | |
| 358,847 | Institution | 0.65% | 14,034,506 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,535,469 | Institution | 6.40% | 139,757,090 | |
| 1,657,813 | Institution | 3.00% | 59,946,518 | |
| 1,453,714 | Institution | 2.63% | 57,465,314 | |
| 1,347,934 | Institution | 2.44% | 52,717,699 | |
| 1,335,837 | Institution | 2.42% | 48,303,866 | |
| 903,954 | Institution | 1.64% | 35,733,302 | |
| 886,853 | Institution | 1.61% | 32,068,604 | |
| 832,676 | Institution | 1.51% | 30,109,564 | |
| 500,636 | Institution | 0.91% | 19,790,141 | |
| 434,060 | Institution | 0.79% | 16,976,087 |
FAQ
Who Owns Supernus Pharmaceuticals (SUPN)?
According to the latest TipRanks data, approximately 29.24% of the company's stock is held by institutional investors, 4.33% is held by insiders, and 1.83% is held by retail investors.
What percentage of Supernus Pharmaceuticals (SUPN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 29.24% of Supernus Pharmaceuticals (SUPN) stock is held by institutional investors.
What percentage of Supernus Pharmaceuticals (SUPN) stock is held by retail investors?
According to the latest TipRanks data, approximately 1.83% of Supernus Pharmaceuticals (SUPN) stock is held by retail investors.
Who owns the most shares of Supernus Pharmaceuticals (SUPN)?
iShares owns the most shares of Supernus Pharmaceuticals (SUPN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.